Foot Locker, Amicus Therapeutics, Valeant Pharmaceuticals News Today

Foot Locker stock is cratering this morning following a disappointing earnings report

May 19, 2017 at 10:16 AM
facebook twitter linkedin


The Dow is on pace to close a volatile week with a second straight win. Among specific stocks on the move are athletic apparel retailer Foot Locker, Inc. (NYSE:FL), biotech Amicus Therapeutics, Inc. (NASDAQ:FOLD), and drug stock Valeant Pharmaceuticals Intl Inc (NYSE:VRX). Here's a quick look at what's moving shares of FL, FOLD, and VRX. 

FL Stock Sells Off After Earnings

Foot Locker stock is getting hammered this morning, after the company reported disappointing first-quarter earnings. FL shares have dropped 16% to trade at $59.21, territory not seen since last August. Short-term FL options traders look well-positioned for the pullback, though. This is based on FL stock's Schaeffer's put/call open interest ratio (SOIR) of 1.11, which ranks in the 94th percentile of its annual range, pointing toward an unusual put-skew among options set to expire in three months or less. 

FOLD Shares Extend 2017 Rally

FOLD stock is up 2.7% at $7.95, after the company said it is on track to report updates for its ESSENCE study in the third quarter. It's been a good year for Amicus Therapeutics shares, which have added 60% year-to-date -- though they've struggled to overcome the $8 level. Analysts are certainly expecting extended upside for FOLD stock. At the moment, all six of the brokerage firms covering FOLD shares rate them a "strong buy." 

VRX Stock Stays Hot

VRX is up 0.1% at $13.49, on news the European Medicines Agency has recommended the approval of the company's psoriasis drug, Brodalumab. Plus, Deutsche Bank reiterated its $18 price target on the drug stock -- territory not seen since late November -- saying it is "warming up" to the shares.

Valeant Pharmaceuticals is now up 62% since its multi-year low of $8.31 from April 24, and VRX options traders have been buying to open calls over puts at a faster-than-usual clip. VRX stock has a 10-day call/put volume ratio of 3.30 at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), which ranks in the 92nd annual percentile. 
 

If you are not making money with options, you aren’t buying options like this…

There is no options strategy that more perfectly approaches trading the fastest moving and most volatile stocks available in the marketplace than this one. In fact, there is no strategy that better utilizes put options for optimal returns and a real trading edge over other traders in the exact same market. New options traders fail out at an incredible rate without proper trade research, execution timing, and option picking. Capitalize on Schaeffer’s 100+ years of options trading excellence with the most coveted product launch in company history. Don't waste another second... join us right now before the next round of trades are released!

 


 


 
Special Offers from Schaeffer's Trading Partners